Quanterix Stock Forecast, Price & News

Quanterix (NASDAQ:QTRX) Frequently Asked Questions

Is Quanterix a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last twelve months. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Quanterix stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTRX, but not buy additional shares or sell existing shares.
View analyst ratings for Quanterix or view top-rated stocks.

What stocks does MarketBeat like better than Quanterix?

Wall Street analysts have given Quanterix a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quanterix wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Quanterix?

Quanterix saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,140,000 shares, an increase of 33.1% from the August 31st total of 856,400 shares. Based on an average daily trading volume, of 253,600 shares, the short-interest ratio is currently 4.5 days. Currently, 3.5% of the company's stock are sold short.
View Quanterix's Short Interest.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Quanterix.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) posted its quarterly earnings data on Thursday, August, 5th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.01. The business had revenue of $25.37 million for the quarter, compared to analyst estimates of $23.59 million. Quanterix had a negative trailing twelve-month return on equity of 8.76% and a negative net margin of 26.90%.
View Quanterix's earnings history.

How has Quanterix's stock been impacted by COVID-19?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, QTRX stock has increased by 172.1% and is now trading at $50.36.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for QTRX?

3 brokerages have issued 12 month price objectives for Quanterix's stock. Their forecasts range from $53.00 to $75.00. On average, they expect Quanterix's share price to reach $66.00 in the next twelve months. This suggests a possible upside of 31.1% from the stock's current price.
View analysts' price targets for Quanterix or view top-rated stocks among Wall Street analysts.

Who are Quanterix's key executives?

Quanterix's management team includes the following people:

• E. Kevin Hrusovsky, Chairman, President & Chief Executive Officer
• William Geist, Chief Operating Officer
• Michael A. Doyle, Chief Financial Officer & Treasurer
• David C. Duffy, Chief Technology Officer & Vice President-Research (LinkedIn Profile)
• Brian P. Keane, Vice President & Senior Legal Counsel

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

Who are some of Quanterix's key competitors?

Some companies that are related to Quanterix include Coherent (COHR), Pacific Biosciences of California (PACB), Olink Holding AB (publ) (OLK), Cytek BioSciences (CTKB), HORIBA (HRIBF), Berkeley Lights (BLI), Bionano Genomics (BNGO), Nobilis Health (HLTH), Singular Genomics Systems (OMIC), Rapid Micro Biosystems (RPID), Akoya Biosciences (AKYA), Fluidigm (FLDM), Accelerate Diagnostics (AXDX), EyePoint Pharmaceuticals (EYPT) and Codex DNA (DNAY).
View all of QTRX's competitors.

What other stocks do shareholders of Quanterix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quanterix investors own include Editas Medicine (EDIT), Novavax (NVAX), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), The Walt Disney (DIS), Illumina (ILMN), Sorrento Therapeutics (SRNE), Cisco Systems (CSCO) and Intellia Therapeutics (NTLA).

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Taylor Cottrill Erickson & Associates Inc. (0.02%). Company insiders that own Quanterix stock include Amol Chaubal, David C Duffy, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, John J Fry, Marijn E Dekkers, Marijn E Dekkers, Mark T Roskey, Mark T Roskey and Martin D Madaus.
View institutional ownership trends for Quanterix.

Which institutional investors are buying Quanterix stock?

QTRX stock was purchased by a variety of institutional investors in the last quarter, including Taylor Cottrill Erickson & Associates Inc..
View insider buying and selling activity for Quanterix or or view top insider-buying stocks.

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $50.36.

How much money does Quanterix make?

Quanterix has a market capitalization of $1.84 billion and generates $86.38 million in revenue each year. The company earns $-31.53 million in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does Quanterix have?

Quanterix employs 314 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

Where are Quanterix's headquarters?

Quanterix is headquartered at 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at (617) 301-9400 or via email at [email protected].